Category:Arash Ash Alizadeh of San Mateo CA (US)

Arash Ash Alizadeh of San Mateo CA (US)

Executive Summary

Arash Ash Alizadeh of San Mateo CA (US) is an inventor who has filed 4 patents. Their primary areas of innovation include BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY (4 patents), for cancer (immunoassay for cancer (4 patents), ICT specially adapted for sequence analysis involving nucleotides or amino acids (4 patents), and they have worked with companies such as The Board of Trustees of the Leland Stanford Junior University (4 patents). Their most frequent collaborators include (4 collaborations), (4 collaborations), (1 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• G16B20/20 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY): 4 patents
• C12Q1/6886 (for cancer (immunoassay for cancer): 4 patents
• G16B30/00 (ICT specially adapted for sequence analysis involving nucleotides or amino acids): 4 patents
• G16B30/10 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY): 4 patents
• G16H10/60 (for patient-specific data, e.g. for electronic patient records): 4 patents
• G16H50/20 (for computer-aided diagnosis, e.g. based on medical expert systems): 4 patents
• C12N15/1089 ({Design, preparation, screening or analysis of libraries using computer algorithms}): 3 patents
• C12Q1/6869 (Methods for sequencing): 3 patents
• C12Q1/6874 (involving nucleic acid arrays, e.g. sequencing by hybridisation): 3 patents
• G16B20/00 (ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations): 3 patents
• G16B20/10 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY): 3 patents
• G16B35/20 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY): 3 patents
• G16B40/00 (ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding): 3 patents
• G16H10/40 (for data related to laboratory analysis, e.g. patient specimen analysis): 3 patents
• G16H20/10 (relating to drugs or medications, e.g. for ensuring correct administration to patients): 3 patents
• G16H50/30 (for calculating health indices; for individual health risk assessment): 3 patents
• G16H50/70 (for mining of medical data, e.g. analysing previous cases of other patients): 3 patents
• G16H70/60 (relating to pathologies): 3 patents
• G16B25/00 (ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression): 1 patents
• G16B25/20 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY): 1 patents
• C12Q1/6813 (Hybridisation assays): 1 patents
• C12Q2600/112 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 1 patents
• C12Q2600/156 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 1 patents
• C12Q2600/158 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 1 patents
• G01N2800/7028 (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing processes other than immunoassay, involving enzymes or microorganisms): 1 patents

Companies

List of Companies

• The Board of Trustees of the Leland Stanford Junior University: 4 patents

Collaborators

• David M. Kurtz of San Carlos CA (US) (4 collaborations)
• Maximilian Diehn of San Carlos CA (US) (4 collaborations)
• Jacob J. Chabon of Arvada CO (US) (1 collaborations)